Friend or foe: Can activating mutations in NOTCH1 contribute to a favorable treatment outcome in patients with T-ALL?

Aviya Goldshtein, Michael Berger*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Friend or foe: Can activating mutations in NOTCH1 contribute to a favorable treatment outcome in patients with T-ALL?'. Together they form a unique fingerprint.

Keyphrases

Biochemistry, Genetics and Molecular Biology

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology